---
title: "Sito Bio released its performance for the first three quarters, with a net loss attributable to the parent company of 69.2303 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263034322.md"
description: "According to the Zhitong Finance APP, Sito Bio released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 749 million yuan, a year-on-year decrease of 2.07%. The net loss attributable to shareholders of the listed company was 69.2303 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 72.3879 million yuan. The basic loss per share was 0.36 yuan"
datetime: "2025-10-28T08:42:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263034322.md)
  - [en](https://longbridge.com/en/news/263034322.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263034322.md)
---

# Sito Bio released its performance for the first three quarters, with a net loss attributable to the parent company of 69.2303 million yuan

According to the Zhitong Finance APP, Sito Bio (300583.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 749 million yuan, a year-on-year decrease of 2.07%. The net loss attributable to shareholders of the listed company was 69.2303 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 72.3879 million yuan. The basic loss per share was 0.36 yuan

### Related Stocks

- [300583.CN](https://longbridge.com/en/quote/300583.CN.md)

## Related News & Research

- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [SOUTHAMPTON WILL NOT PLAY IN CHAMPIONSHIP PLAYOFF FINAL AFTER APPEAL REJECTED- EFL STATEMENT](https://longbridge.com/en/news/287118852.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)